Journal of Pharmacovigilance

Editorial

Drug Discovery and Development: An Insight into Pharmacovigilance

• Prashansa Agrawal

Research Article

Clinical Pharmacist Driven Impact towards Intensive Monitoring and Reporting of Adverse Drug Events in Psychiatric Patients

• Disha A Khoda, Madiwalayya S Ganachari, Tarun Wadhwa, Shashikala Walli, Bhupendra Parihar and Atul Aggarwal

Research Article

The Use of Angiotensin Converting Enzyme Inhibitors during the First Trimester of Pregnancy

• Lyn Colvin, Barry NJ Walters, Andrew W Gill, Linda Slack-Smith, Fiona J Stanley, Lolkje TW De Jong-Van De Berg and Carol Bower

Research Article

Motivations and Obstacles for Adverse Drug Reactions Reporting among Healthcare Professionals from the Perspective of Lewin’s Force Field Analysis Theory: Analytic Approach

• Ramadan M Elkalmi, Omar Q Al-lela and Shazia Q Jamshed

Case Report

Chronic Hepatitis C (CHC) Treatment in Two Cystic Fibrosis (CF) Patients

• Marianna Passiu, Ilaria Meneghelli and Baroukh Maurice Assael

Short Communication

Pharmacovigilance Legal Requirements for Marketing Authorization Holders in Spain

• Jose Alberto Ayala Ortiz

Research Letter

Bayesian Approach to Urinary ESBL-Producing Escherichia coli

• osé Miguel Sahuquillo-Arce, Hèctor Perpiñán, Carmen Armero, Antonio López-Quílez, María Selva and Francisco González

Short Communication

Global Health Systems

• Jack Warren Salmon

Review Article

A Review on Adverse Drug Events to Create Awareness

• Pallavi Jaiswal